Table 1 Patient demographic data. logMAR = logarithm of the minimum angle of resolution; VA = visual acuity.
Number of patients | 6 |
Number of eyes | 7 |
Age | 66.0 ± 8.6 |
Gender | |
Male (%) | 4 (66.6) |
Female (%) | 2 (33.3) |
Causative disease (%) | |
Proliferative diabetic retinopathy | 5 (71.4%) |
Central retinal vein occlusion | 1 (14.3%) |
Central retinal artery occlusion | 1 (14.3%) |
Number of previous anti-VEGF agent injections | 2.0 ± 1.6 |
Number of patients who treated with an anti-VEGF agent (%) | |
Bevacizumab | 6 (85.7%) |
Aflibercept | 1 (14.3%) |
Pre-injection VA (logMAR) | 1.07 ± 1.02 |
Pre-injection IOP (mmHg) | 33.4 ± 17.1 |
Post-injection VA (logMAR) | 1.12 ± 1.10 |
Post-injection IOP (mmHg) | 15.9 ± 5.8 |
Days of image acquisition after last anti-VEGF drug injection | 20.1 ± 11.9 |
